Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Bristol John W & Co. Inc. NY

Bristol John W & Co. Inc. NY decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 19.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 281,912 shares of the medical equipment provider's stock after selling 67,971 shares during the quarter. Intuitive Surgical makes up approximately 2.4% of Bristol John W & Co. Inc. NY's portfolio, making the stock its 16th biggest position. Bristol John W & Co. Inc. NY owned approximately 0.08% of Intuitive Surgical worth $147,147,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the fourth quarter valued at $25,000. Hurley Capital LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $28,000. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $28,000. Finally, Summit Securities Group LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at about $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on ISRG. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Citigroup reaffirmed a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Royal Bank of Canada reduced their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Barclays reduced their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Finally, Piper Sandler reduced their price target on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $596.05.

Insider Activity at Intuitive Surgical

In other news, EVP Myriam Curet sold 3,031 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $577.30, for a total value of $1,749,796.30. Following the completion of the sale, the executive vice president now owns 353 shares of the company's stock, valued at approximately $203,786.90. This represents a 89.57% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares of the company's stock, valued at $2,793,033.06. The trade was a 60.72% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 30,111 shares of company stock worth $15,364,055. Insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Down 0.8%

ISRG stock traded down $4.61 during mid-day trading on Friday, hitting $551.14. The company had a trading volume of 2,091,011 shares, compared to its average volume of 1,647,905. The company has a market capitalization of $197.54 billion, a price-to-earnings ratio of 85.98, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 12-month low of $396.48 and a 12-month high of $616.00. The company has a 50-day moving average price of $516.44 and a 200 day moving average price of $538.53.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the company earned $1.50 EPS. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.